Furthermore, we found beneficial-cluster of specific methylation markers (PCDH20, APCDD1, COCH) that could be used in conjunction with microsatellite status to expand the pool of colon cancer patients eligible for immunotherapy. The gene discussed is APCDD1; the disease is malignant colon neoplasm.